Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
2.510
-0.160 (-5.99%)
At close: Apr 1, 2025, 4:00 PM
2.532
+0.022 (0.89%)
After-hours: Apr 1, 2025, 5:05 PM EDT

Achieve Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
16.2511.4410.729.137.87
Upgrade
Research & Development
22.8215.8130.0823.976.88
Upgrade
Operating Expenses
39.0727.2540.833.0914.75
Upgrade
Operating Income
-39.07-27.25-40.8-33.09-14.75
Upgrade
Interest Expense
-2.18-2.85-1.79--
Upgrade
Interest & Investment Income
2.360.830.20.020.07
Upgrade
Other Non Operating Income (Expenses)
-0.03-0.010.04-0.08-0.05
Upgrade
EBT Excluding Unusual Items
-38.92-29.29-42.35-33.15-14.73
Upgrade
Other Unusual Items
-0.9-0.53---
Upgrade
Pretax Income
-39.83-29.82-42.35-33.15-14.73
Upgrade
Net Income
-39.83-29.82-42.35-33.15-14.73
Upgrade
Net Income to Common
-39.83-29.82-42.35-33.15-14.73
Upgrade
Shares Outstanding (Basic)
32201183
Upgrade
Shares Outstanding (Diluted)
32201183
Upgrade
Shares Change (YoY)
61.75%87.17%30.46%198.64%559.42%
Upgrade
EPS (Basic)
-1.24-1.50-4.00-4.08-5.42
Upgrade
EPS (Diluted)
-1.24-1.50-4.00-4.08-5.42
Upgrade
Free Cash Flow
-29.77-24.5-37.57-29.44-13.49
Upgrade
Free Cash Flow Per Share
-0.93-1.24-3.55-3.63-4.96
Upgrade
EBITDA
-38.84-27.02-40.56-32.84-14.5
Upgrade
D&A For EBITDA
0.230.230.240.250.26
Upgrade
EBIT
-39.07-27.25-40.8-33.09-14.75
Upgrade
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q